You are here: Home » News-ANI » Science
Business Standard

Optical imaging technology may help better treat cancer, brain diseases: Study

Health Medical Pharma


Researchers have discovered a new tool for medical professionals that may help shed more light on tumours in the body and how the brain operates.

Purdue University researchers created technology that uses optical imaging to aid surgeons map out tumours in the body and help them understand how certain diseases affect activity in the brain. The work is published in the journal IEEE Transactions on Medical Imaging.

"We are using light to extract new information from tissue to inform doctors and assist them in designing and carrying out surgeries to remove tumours," said Brian Bentz, a Purdue alumnus, who worked on the technology with Kevin Webb, a professor of electrical and computer engineering at Purdue.

"It is a localisation method where our technology helps the surgeon pinpoint precise information about the depth and location of tumours. Such information is not easily accessible with current technologies," Bentz added.

The Purdue technology uses contrast in the absorption of light and fluorescent agents that are introduced into the body to find tumours and/or blood vessels within the tissue. The same technology can be used to study neuron activation in the brain, which can help doctors detect diseases such as Parkinson's.

Bentz said that the Purdue technology overcomes one of the major challenges with fluorescence imaging -- the light becomes highly scattered and that limits the information a surgeon receives.

"Our technology aims to provide more detailed information about tumours for surgeons and neuron activity in the brain, both of which can improve outcomes for patients," Bentz added.

The innovators are working with the Purdue Research Foundation Office of Technology Commercialisation to patent the technology.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, April 10 2020. 07:54 IST